cbdMD, Inc. Form 8-K Summary
Business Context and Reporting Period
cbdMD, Inc. (NYSE American: YCBD), an emerging growth company incorporated in North Carolina, filed this Current Report on August 4, 2020. The filing primarily serves to announce the unaudited net sales results for its subsidiary, Paw CBD, Inc., for the third quarter of fiscal 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing the unaudited net sales figures for the Paw CBD, Inc. subsidiary, but the specific dollar amounts are not included in the body of this 8-K document.
Material Changes
No comparative financial data or material changes versus prior periods are detailed within this specific filing text. The document acts as a notification of the release of subsidiary sales data rather than a comprehensive financial statement.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 4, 2020) for the specific unaudited net sales figures of Paw CBD, Inc.
- Verify the full financial context of the third quarter of fiscal 2020 in the company's subsequent quarterly report (Form 10-Q).
- Confirm the status of the 8% Series A Cumulative Convertible Preferred Stock (YCBD PR A) and common stock (YCBD) trading on NYSE American.
- Note that the data provided in this 8-K is unaudited and furnished, not filed, limiting its legal liability status.